Microscopic colitis: A review of etiology, treatment and refractory disease
UMass Chan AffiliationsDepartment of Medicine, Division of Gastroenterology
Document TypeJournal Article
Etiology of microscopic colitis
Refractory microscopic colitis
Steroid-dependent microscopic colitis
Digestive System Diseases
Immune System Diseases
MetadataShow full item record
AbstractMicroscopic colitis is a common cause of chronic, nonbloody diarrhea. Microscopic colitis is more common in women than men and usually affects patients in their sixth and seventh decade. This article reviews the etiology and medical management of microscopic colitis. The etiology of microscopic colitis is unknown, but it is associated with autoimmune disorders, such as celiac disease, polyarthritis, and thyroid disorders. Smoking has been identified as a risk factor of microscopic colitis. Exposure to medications, such as non-steroidal anti-inflammatory drugs, proton pump inhibitors, and selective serotonin reuptake inhibitors, is suspected to play a role in microscopic colitis, although their direct causal relationship has not been proven. Multiple medications, including corticosteroids, anti-diarrheals, cholestyramine, bismuth, 5-aminosalicylates, and immunomodulators, have been used to treat microscopic colitis with variable response rates. Budesonide is effective in inducing and maintaining clinical remission but relapse rate is as high as 82% when budesonide is discontinued. There is limited data on management of steroid-dependent microscopic colitis or refractory microscopic colitis. Immunomodulators seem to have low response rate 0%-56% for patients with refractory microscopic colitis. Response rate 66%-100% was observed for use of anti-tumor necrosis factor (TNF) therapy for refractory microscopic colitis. Anti-TNF and diverting ileostomy may be an option in severe or refractory microscopic colitis.
SourceWorld J Gastroenterol. 2015 Aug 7;21(29):8804-10. doi: 10.3748/wjg.v21.i29.8804. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/39827
Related ResourcesLink to Article in PubMed
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Showing items related by title, author, creator and subject.
Management of microscopic colitis: challenges and solutionsShor, Julia; Churrango, Gustavo; Hosseini, Nooshin; Marshall, Christopher (2019-02-27)Microscopic colitis (MC) is a chronic inflammatory bowel disease characterized by nonbloody diarrhea in the setting of normal appearing colonic mucosa. MC has two main subtypes based on histopathologic features, collagenous colitis and lymphocytic colitis. Management of both subtypes is the same, with treatment goal of reducing the number of bowel movements and improving consistency. First-line treatment involves counseling the patient about decreasing their risk factors, like discontinuing smoking and avoiding medications with suspected association such as NSAIDs, proton pump inhibitor, ranitidine, and sertraline. Starting loperamide for immediate symptomatic relief is used as an adjunct to therapy with glucocorticoids. Budesonide is considered first-line treatment for MC given its favorable side effect profile and good efficacy, though relapse rates are high. Systemic glucocorticoids should be reserved to patients unable to take budesonide. In glucocorticoid refractory disease, medications that have been tried include cholestyramine, bismuth salicylate, antibiotics, probiotics, aminosalicylates, immunomodulators, and anti-tumor necrosis factor-alpha inhibitors. More research is needed for the creation of a systematic stepwise approach for relapsing and refractory disease.
The Molecular Mechanism of RIPK1-Induced Cell Death And Its Impact On The Immune ResponsePark, Christa (2023-04-25)Receptor-interacting serine/threonine protein kinase 1 (RIPK1) is a critical adapter protein with pleiotropic functions that regulate cell survival and death. RIPK1 is essential for immune homeostasis and thus is closely controlled during development and inflammation. RIPK1 overexpression has been implicated in multiple inflammatory disorders such as multiple sclerosis, atherosclerosis, cardiovascular disease, obesity, psoriasis, and tumor growth. To study the effects of the overactivation of RIPK1, a system was established that drives its overexpression in mouse fibroblasts. Remarkably, the overexpression of RIPK1 resulted in the induction of both apoptosis and necroptosis. While apoptosis is known to be immunologically silent, necroptosis is highly inflammatory. Additional assays using chemical inhibitors and genetic knockout mice established that RIPK1 kinase activity promotes both types of cell death. Furthermore, RIPK1-induced apoptosis and necroptosis require caspase 8 and MLKL, respectively, and the absence of both caspase 8 and MLKL inhibits RIPK1-induced cell death. RIPK1 induction activates NF-κB/MAPK and increases cytokine/chemokine production driven by cell death. This system was further explored to elucidate the effects of RIPK1-induced cell death on immune effector cells, revealing that RIPK1-induced apoptosis and necroptosis can promote DC activation. Lastly, to study the role of RIPK1 in DCs and its contribution to intestinal homeostasis and injury, mice lacking RIPK1 in the DC population were characterized. Importantly, RIPK1 functions in DCs to support colon homeostasis, but also plays a detrimental role during DSS-induced colitis. Collectively, these data further provide novel insights into the multifaceted functions of RIPK1 in cell death and inflammation, highlighting its critical contributions to the immune response.
Construction of a Virtual Microscope that can Accurately Assess Diagnoses Rendered Over the WebDiNino, Ernest (2004-06-01)Background:A Virtual Microscope was designed to serve as an interactive microscope emulator that presents, via the Internet, a complete digitized pathology tissue section. It mimics the use of a microscope in both the stepwise increase in magnification and in lateral motion in the X and Y Cartesian directions. This permits a pathologist to navigate to any area on a slide, at any magnification, similar to a conventional microscope. Objective:The aim of this study was to construct a Virtual Microscope and assess the accuracy of diagnoses rendered over the Web. Methods:: 10 hemotoxalin & eosin stained glass slides comprised of cases from the general surgical pathology section of the University of Massachusetts Medical Center were randomly selected and digitized. They were then presented to 5 pathologists at various levels of training over the Internet. Participants were asked to examine each slide online and provide a diagnostic classification, comments, and confidence level using online feedback forms. Results:The overall concordance rate with the standard diagnosis was 44/50 (88%). This includes participants who submitted the standard diagnosis as part of a differential diagnosis. All participants were able to correctly diagnose the major pathologic process (i.e. benign vs. malignant) for each virtual slide 50/50 (100%). Factors which negatively influenced confidence were cited a total of 52 times. Poor image quality was cited in 20 out of 50 cases (40%), patient history was cited as necessary in 5 of 50 cases (10%), insufficient tissue was cited in 5 of 50 cases (10%), insufficient magnification was cited in 10 of 50 cases (20%), and more workup (i.e. immunohistochemical) was cited as necessary in 12 of 50 cases (24%). Image quality, image magnification, and a participant’s level of confidence in a specific diagnosis are not correlated with diagnostic accuracy. Level of training was associated with perceived negative factors regarding the virtual slide format, but was not associated with diagnostic accuracy. Conclusion:: Results from this study indicate that Virtual Microscopy can be used to make a correct diagnosis. Drawbacks include the need for high speed Internet connectivity and the availability of only one focal plane. However virtual microscopy may be considered a useful tool in medical school education, distance learning, and remote diagnosis.